Actively Recruiting

Age: 18Years +
All Genders
NCT07302607

Predictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021

Led by University Hospital, Strasbourg, France · Updated on 2025-12-24

221

Participants Needed

1

Research Sites

55 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Although impressive progress has been made with this new therapeutic strategy, only a proportion of patients achieve a complete and sustained response. Studies have already identified predictive factors of treatment response that are now widely recognized. In this study, the investigators aim to identify other response factors not yet evaluated in the literature.

CONDITIONS

Official Title

Predictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age �38 18 years
  • Unresectable stage III or stage IV melanoma according to the AJCC classification - 8th edition
  • Curative immunotherapy treatment (anti-PD-1 and/or anti-CTLA-4)
  • Treatment and follow-up at the Dermatology Department of the Strasbourg University Hospitals
  • Immunotherapy initiated between January 1, 2013, and December 31, 2021
Not Eligible

You will not qualify if you...

  • Primary choroidal melanoma
  • Adjuvant-intent immunotherapy
  • Less than 3 months of follow-up after the start of immunotherapy
  • Change of treatment before the first reassessment
  • Treatment and follow-up at a department other than the Dermatology Department of the Strasbourg University Hospitals

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Service de dermatologie - Réanimation - CHU de Strasbourg - France

Strasbourg, France, 67091

Actively Recruiting

Loading map...

Research Team

C

Cédric LENORMAND, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here